Health Evaluation of Abilify Long-term Therapy

Clinical trial NCT00520650 · COMPLETED

Trial details

NCT number: NCT00520650
Sponsor: Taiwan Otsuka Pharm. Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2006-08-01
Primary completion: 2009-04-01
Enrollment: 245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.